Literature DB >> 23602369

HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.

Thorsten Rieckmann1, Silke Tribius, Tobias J Grob, Felix Meyer, Chia-Jung Busch, Cordula Petersen, Ekkehard Dikomey, Malte Kriegs.   

Abstract

BACKGROUND AND
PURPOSE: When treated by radiotherapy, patients with squamous cell carcinomas of the head and neck (HNSCC) positive for HPV and p16(INK4a) possess a clearly favorable prognosis as compared to those with HPV-negative HNSCC. The aim of this work was to study whether the better outcomes might be caused by an enhanced cellular radiosensitivity.
MATERIALS AND METHODS: The radiation response of five HPV/p16(INK4a)-positive and five HPV-negative cell lines was characterized with regard to cellular radiosensitivity by colony formation assay. Furthermore G1- and G2-arrest, apoptosis and residual DNA double-strand breaks (DSB) were analyzed by the colcemid-based G1-efflux assay, propidium iodide staining, the detection of PARP cleavage, the fluorescence-based detection of caspase activity and the immunofluorescence staining of γH2AX and 53BP1 foci.
RESULTS: On average, the cellular radiosensitivity of the HNSCC cell lines positive for HPV and p16(INK4a) was higher as compared to the sensitivity of a panel of five HPV-negative HNSCC cell lines (SF3=0.2827 vs. 0.4455). The higher sensitivity does not result from increased apoptosis or the execution of a permanent G1-arrest, but is rather associated with both, elevated levels of residual DSBs and extensive G2-arrest.
CONCLUSIONS: Increased cellular radiosensitivity due to compromised DNA repair capacity is likely to contribute to the improved outcome of patients with HPV/p16(INK4a)-positive tumors when treated by radiotherapy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602369     DOI: 10.1016/j.radonc.2013.03.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  117 in total

1.  Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.

Authors:  Christina A Wicker; Brian G Hunt; Sunil Krishnan; Kathryn Aziz; Shobha Parajuli; Sarah Palackdharry; William R Elaban; Trisha M Wise-Draper; Gordon B Mills; Susan E Waltz; Vinita Takiar
Journal:  Cancer Lett       Date:  2021-01-12       Impact factor: 8.679

2.  Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.

Authors:  C Cleary; J E Leeman; D S Higginson; N Katabi; E Sherman; L Morris; S McBride; N Lee; N Riaz
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-04-01       Impact factor: 4.126

3.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines.

Authors:  Mei Zhang; Barbara Rose; C Soon Lee; Angela M Hong
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

5.  Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.

Authors:  Rosemarie Krupar; Katharina Robold; Doris Gaag; Gerrit Spanier; Marina Kreutz; Kathrin Renner; Claus Hellerbrand; Ferdinand Hofstaedter; Anja K Bosserhoff
Journal:  Virchows Arch       Date:  2014-07-16       Impact factor: 4.064

6.  The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

Authors:  Randall J Kimple; Paul M Harari
Journal:  Ann Transl Med       Date:  2015-05

Review 7.  Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer.

Authors:  Janice Cho; Daniel E Johnson; Jennifer R Grandis
Journal:  Semin Radiat Oncol       Date:  2018-01       Impact factor: 5.934

Review 8.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

Review 9.  Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.

Authors:  Grace C Blitzer; Molly A Smith; Stephen L Harris; Randall J Kimple
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-15       Impact factor: 7.038

Review 10.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.